NYSE:NEP • US65341B1061
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NEXTERA ENERGY PARTNERS LP (NEP).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-02-03 | Barclays | Maintains | Underweight -> Underweight |
| 2025-02-03 | Morgan Stanley | Downgrade | Overweight -> Underweight |
| 2025-01-29 | Guggenheim | Maintains | Neutral -> Neutral |
| 2025-01-29 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-01-29 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-29 | Jefferies | Maintains | Buy -> Buy |
| 2025-01-23 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-01-13 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2025-01-08 | CIBC | Maintains | Neutral -> Neutral |
| 2024-12-12 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2024-12-02 | Morgan Stanley | Upgrade | Underweight -> Overweight |
| 2024-10-28 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-10-28 | Seaport Global | Maintains | Sell -> Sell |
| 2024-10-24 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-10-24 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2024-10-24 | Jefferies | Maintains | Buy -> Buy |
| 2024-10-22 | CIBC | Maintains | Neutral -> Neutral |
| 2024-10-21 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-10-09 | Mizuho | Maintains | Neutral -> Neutral |
| 2024-10-04 | Barclays | Maintains | Underweight -> Underweight |
| 2024-10-01 | Exane BNP Paribas | Initiate | Underperform |
| 2024-09-30 | UBS | Maintains | Neutral -> Neutral |
| 2024-09-19 | Jefferies | Initiate | Buy |
| 2024-07-31 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2024-07-25 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.211B 23.32% | 1.078B -10.98% | 1.23B 14.10% | 1.374B 11.71% | 1.367B -0.51% | 1.398B 2.27% | 1.487B 6.37% | 1.622B 9.08% | |
| EBITDA YoY % growth | 734M 12.75% | 607M -17.30% | 734M 20.92% | 1.96B 167.03% | 1.913B -2.40% | 1.887B -1.36% | 1.883B -0.21% | 1.973B 4.78% | |
| EBIT YoY % growth | 161M -34.55% | -28M -117.39% | 102M 464.29% | 261.09M 155.97% | 229.88M -11.95% | 476.77M 107.40% | 501.97M 5.29% | 618.12M 23.14% | |
| Operating Margin | 13.29% | -2.60% | 8.29% | 19.00% | 16.82% | 34.10% | 33.76% | 38.11% | |
| EPS YoY % growth | 5.66 210.99% | 2.13 -62.37% | 5.65 165.26% | 2.41 -57.38% | 2.27 -5.57% | 3.51 54.58% | 0.51 -85.63% | 0.52 2.00% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.11 -84.82% | 0.58 -12.08% | 0.58 233.94% | 0.45 -90.45% | 0.31 174.94% | 0.64 10.53% | 0.44 -23.72% | 0.42 -6.00% | 0.01 -96.77% | 1.76 174.02% | 1.58 258.62% |
| Revenue Q2Q % growth | 280.17M 9.02% | 376.26M 4.52% | 363.71M 14.02% | 319.68M 8.73% | 287.62M 2.66% | 352.41M -6.34% | 346.96M -4.61% | 280.73M -12.18% | 534.18M 85.72% | 632.56M 79.50% | 604.82M 74.32% |
| EBITDA Q2Q % growth | 446.53M 228.33% | 530.69M 39.29% | 514.78M 1.14% | 469M -28.29% | 509.88M 14.19% | 567.41M 6.92% | 532.74M 3.49% | 483.68M 3.13% | 673.76M 32.14% | 772.15M 36.08% | 744.4M 39.73% |
| EBIT Q2Q % growth | 5.656M 126.93% | 114.33M 73.23% | 99.047M 182.99% | 63.125M 186.93% | 163.95M 2,798.69% | 216.44M 89.31% | 211.05M 113.08% | 162M 156.63% | 488.4M 197.90% | 586.78M 171.11% | 559.04M 164.89% |
All data in USD
24 analysts have analysed NEP and the average price target is 20.84 USD. This implies a price increase of 97.7% is expected in the next year compared to the current price of 10.54.
The consensus EPS estimate for the next earnings of NEXTERA ENERGY PARTNERS LP (NEP) is 0.11 USD and the consensus revenue estimate is 280.17M USD.
The consensus rating for NEXTERA ENERGY PARTNERS LP (NEP) is 54.1667 / 100 . This indicates that analysts generally have a neutral outlook on the stock.